5X7D | pdb_00005x7d

Structure of beta2 adrenoceptor bound to carazolol and an intracellular allosteric antagonist


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free: 
    0.268 (Depositor), 0.279 (DCC) 
  • R-Value Work: 
    0.222 (Depositor), 0.238 (DCC) 
  • R-Value Observed: 
    0.226 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5X7D

Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history

Literature

Mechanism of intracellular allosteric beta 2AR antagonist revealed by X-ray crystal structure.

Liu, X.Ahn, S.Kahsai, A.W.Meng, K.C.Latorraca, N.R.Pani, B.Venkatakrishnan, A.J.Masoudi, A.Weis, W.I.Dror, R.O.Chen, X.Lefkowitz, R.J.Kobilka, B.K.

(2017) Nature 548: 480-484

  • DOI: https://doi.org/10.1038/nature23652
  • Primary Citation Related Structures: 
    5X7D

  • PubMed Abstract: 

    G-protein-coupled receptors (GPCRs) pose challenges for drug discovery efforts because of the high degree of structural homology in the orthosteric pocket, particularly for GPCRs within a single subfamily, such as the nine adrenergic receptors. Allosteric ligands may bind to less-conserved regions of these receptors and therefore are more likely to be selective. Unlike orthosteric ligands, which tonically activate or inhibit signalling, allosteric ligands modulate physiologic responses to hormones and neurotransmitters, and may therefore have fewer adverse effects. The majority of GPCR crystal structures published to date were obtained with receptors bound to orthosteric antagonists, and only a few structures bound to allosteric ligands have been reported. Compound 15 (Cmpd-15) is an allosteric modulator of the β 2 adrenergic receptor (β 2 AR) that was recently isolated from a DNA-encoded small-molecule library. Orthosteric β-adrenergic receptor antagonists, known as beta-blockers, are amongst the most prescribed drugs in the world and Cmpd-15 is the first allosteric beta-blocker. Cmpd-15 exhibits negative cooperativity with agonists and positive cooperativity with inverse agonists. Here we present the structure of the β 2 AR bound to a polyethylene glycol-carboxylic acid derivative (Cmpd-15PA) of this modulator. Cmpd-15PA binds to a pocket formed primarily by the cytoplasmic ends of transmembrane segments 1, 2, 6 and 7 as well as intracellular loop 1 and helix 8. A comparison of this structure with inactive- and active-state structures of the β 2 AR reveals the mechanism by which Cmpd-15 modulates agonist binding affinity and signalling.


  • Organizational Affiliation
    • Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China.

Macromolecule Content 

  • Total Structure Weight: 58.95 kDa 
  • Atom Count: 3,669 
  • Modeled Residue Count: 440 
  • Deposited Residue Count: 500 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Chimera protein of Beta-2 adrenergic receptor and Lysozyme500Homo sapiensTequatrovirus T4
This entity is chimeric
Mutation(s): 3 
Gene Names: ADRB2ADRB2RB2AReT4Tp126
EC: 3.2.1.17
Membrane Entity: Yes 
UniProt & NIH Common Fund Data Resources
Find proteins for P00720 (Enterobacteria phage T4)
Explore P00720 
Go to UniProtKB:  P00720
Find proteins for P07550 (Homo sapiens)
Explore P07550 
Go to UniProtKB:  P07550
PHAROS:  P07550
GTEx:  ENSG00000169252 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsP00720P07550
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 6 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
8VS

Query on 8VS



Download:Ideal Coordinates CCD File
F [auth A]4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]-L-phenylalanyl-3-bromo-N-methyl-L-phenylalaninamide
C34 H39 Br N4 O4
MZHSBVCCCRUZKX-DTXPUJKBSA-N
CLR

Query on CLR



Download:Ideal Coordinates CCD File
D [auth A],
E [auth A]
CHOLESTEROL
C27 H46 O
HVYWMOMLDIMFJA-DPAQBDIFSA-N
CAU

Query on CAU



Download:Ideal Coordinates CCD File
G [auth A](2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol
C18 H22 N2 O2
BQXQGZPYHWWCEB-ZDUSSCGKSA-N
EPE

Query on EPE



Download:Ideal Coordinates CCD File
B [auth A],
C [auth A]
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
C8 H18 N2 O4 S
JKMHFZQWWAIEOD-UHFFFAOYSA-N
BU1

Query on BU1



Download:Ideal Coordinates CCD File
H [auth A]1,4-BUTANEDIOL
C4 H10 O2
WERYXYBDKMZEQL-UHFFFAOYSA-N
ACM

Query on ACM



Download:Ideal Coordinates CCD File
I [auth A]ACETAMIDE
C2 H5 N O
DLFVBJFMPXGRIB-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free:  0.268 (Depositor), 0.279 (DCC) 
  • R-Value Work:  0.222 (Depositor), 0.238 (DCC) 
  • R-Value Observed: 0.226 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 40.46α = 90
b = 75.71β = 90
c = 173.41γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2017-08-16
    Type: Initial release
  • Version 1.1: 2017-08-30
    Changes: Database references
  • Version 1.2: 2017-09-06
    Changes: Database references
  • Version 1.3: 2022-10-12
    Changes: Database references, Other
  • Version 1.4: 2023-10-18
    Changes: Data collection, Refinement description
  • Version 1.5: 2024-11-06
    Changes: Structure summary